menu
    • menu

    Company profile for Shorla Oncology

    NEW Drugs in Dev: 6
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development an...
    At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shorla OncologyIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    Questum Acceleration Center Ballingarrane Science & Technology Park Clonmel, C...
    Telephone
    Telephone
    +353 (052) 618 4362
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://shorlaoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/shorla-pharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ShorlaOncology

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Asia Pharma Expo

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shorla Oncology Gets FDA Nod For Bigger Nelarabine Vial
    Shorla Oncology Gets FDA Nod For Bigger Nelarabine Vial

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127385856/en/Shorla-Oncology-Announces-U.S.-FDA-Approval-of-Larger-Vial-Size-for-Nelarabine-Intravenous-Administration-for-the-Treatment-of-T-cell-Acute-Lymphoblastic-Leukemia-and-T-cell-Lymphoblastic-Lymphoma

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Shorla Gets FDA Orphan Tag for SH-110 Brain Cancer Drug
    Shorla Gets FDA Orphan Tag for SH-110 Brain Cancer Drug

    15 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250715632403/en/Shorla-Oncology-Announces-FDA-Orphan-Drug-Designation-for-SH-110-to-Treat-Rare-Brain-Cancer-Using-Oral-Liquid

    BUSINESSWIRE
    15 Jul 2025
    Share Share
    Shorla Oncology FDA approves Tepylute for breast and ovarian Cancer
    Shorla Oncology FDA approves Tepylute for breast and ovarian Cancer

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250429747360/en/Shorla-Oncology-Announces-FDA-Approval-of-TEPYLUTE-100mg-First-and-Only-Ready-to-Dilute-Multi-Dose-Vial-of-Thiotepa-to-Treat-Breast-and-Ovarian-Cancer-and-Commercial-Launch-of-TEPYLUTE-15mg-and-100mg-Vials-in-the-U.S.

    BUSINESSWIRE
    29 Apr 2025
    Share Share
    Shorla Expands U.S. Presence With Sales, Market Access Teams
    Shorla Expands U.S. Presence With Sales, Market Access Teams

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304027981/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
    Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI

    28 Nov 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/shilpa-medicares-jv-oncosol-gets-usfda-approval-for-imkeldi-16490

    INDPHARMAPOST
    28 Nov 2024
    Share Share
    Shorla gains FDA nod for 1st oral version of Novartis' Gleevec
    Shorla gains FDA nod for 1st oral version of Novartis' Gleevec

    27 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241125044117/en/Shorla-Oncology-Announces-FDA-Approval-of-IMKELDI-imatinib-Oral-Solution-an-Oral-Liquid-for-the-Treatment-of-Certain-Forms-of-Leukemia-and-Other-Cancers

    BUSINESSWIRE
    27 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search